Exploring the level of metabolic reprogramming and the role of prognostic factor SF3A3 in hepatocellular carcinoma through integrated single-cell landscape analysis.
This study aims to investigate metabolic reprogramming heterogeneity in hepatocellular carcinoma (HCC) cells and identify novel therapeutic targets for HCC treatment. Single-cell RNA sequencing data from public databases were used to analyze the TME of HCC and reveal the characteristics of different...
Saved in:
| Main Authors: | Wanshuo Wei, Yuan Gan, Xindan Zhang, Yumo Chen, Zengfeng Huang, Shuhan Wang, Xiaomei Xie, Yongle Li, Pengtao Qin, Lihe Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0323559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TM9SF4 is a potential prognostic biomarker in hepatocellular carcinoma
by: Yahui Ma, et al.
Published: (2025-04-01) -
Interaction of STIL with FOXM1 regulates SF3A3 transcription in the hepatocellular carcinoma development
by: Haijun Zhang, et al.
Published: (2025-01-01) -
Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma
by: Shadi Chamseddine, et al.
Published: (2024-11-01) -
Bioinformatics analysis across pan-cancer and experimental validation in hepatocellular carcinoma revealed the oncogenic role of SF3B6
by: Linshuang Tu, et al.
Published: (2025-04-01) -
Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications
by: Sujin Park, et al.
Published: (2025-03-01)